FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance–Induced Autophagy Disorder in Diabetic Kidney Disease
Diabetes · 01.09.2026 · 75 (9) · 1657-1672
DOI: 10.2337/db26-0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 22.07.2026. Verfasst von Shaozheng Ai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital, Xining, Qinghai Province, China. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Receptors, Fc, Autophagy. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease worldwide, despite therapeutic advances. Podocyte injury constitutes a critical pathogenic process in DKD. This study elucidated the role of the neonatal Fc receptor (FcRn) in DKD-associated podocyte injury. In DKD, glomerular FcRn expression was markedly elevated and inversely correlated with podocin levels. In diabetic mice, podocyte-specific FcRn deficiency significantly ameliorated insulin resistance and mitigated podocyte damage. Mechanistically, FcRn upregulation in diabetic podocytes exacerbated insulin resistance, suppressed AKT/mTOR signaling, and impaired autophagy, thereby promoting podocyte injury. These findings identify FcRn as a pivotal contributor to podocyte injury in DKD and suggest that FcRn targeting represents a promising therapeutic strategy. Article Highlights Neonatal Fc receptor (FcRn) mediates podocyte injury in immune complex nephropathies, but its role in diabetic kidney disease (DKD) remains undefined. This study demonstrates marked FcRn upregulation in DKD podocytes and elucidates the functional consequences of podocyte FcRn deficiency. FcRn deficiency protects podocytes in DKD by restoring autophagy via enhanced insulin sensitivity and subsequent AKT/mTOR signaling activation. These findings identify FcRn as a novel therapeutic target for DKD, offering a strategy to mitigate the substantial residual risk of disease progression despite current therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital, Xining, Qinghai Province, China.
- Clinical Research Center for Chronic Kidney Disease in Qinghai Province, Xining, Qinghai Province, China.
- Department of Nephrology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
- Department of Nephrology, Beijing Hospital, Beijing, China.
ORCID-Profile: Shaozheng Ai, Chun Zhang, Pengli Luo
Zitieren
APA
Ai, S., Ding, Y., Zhang, C., Li, Z., Yang, Y., Sun, X., Ma, M., Wang, Y., & Luo, P. (2026). FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance–Induced Autophagy Disorder in Diabetic Kidney Disease. Diabetes, 75(9), 1657-1672. https://doi.org/10.2337/db26-0008
Vancouver
Ai S, Ding Y, Zhang C, Li Z, Yang Y, Sun X, et al. FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance–Induced Autophagy Disorder in Diabetic Kidney Disease. Diabetes. 2026;75(9):1657-1672. doi:10.2337/db26-0008
BibTeX
@article{Ai2026,
author = {Ai, Shaozheng and Ding, Yanlin and Zhang, Chun and Li, Zhan and Yang, Yanyan and Sun, Xue and Ma, Mei and Wang, Yan and Luo, Pengli},
title = {FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance–Induced Autophagy Disorder in Diabetic Kidney Disease},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {9},
pages = {1657--1672},
doi = {10.2337/db26-0008}
}
EUVIMED